PEAR - Pear Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Pear Therapeutics's activity chart (see below) currently has 17 price targets and 21 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from CHARDAN CAPITAL on 20-Mar-2023.

Best performing analysts who are covering PEAR - Pear Therapeutics:

Marie Thibault Keay Nakae Judah Frommer Charles Rhyee Neena Bitritto-Garg

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 20-Mar-2023

$8

3 years 5 months 26 days ago
(20-Mar-2023)

0/5 (0%)

$5.51 (221.29%)

Buy Since 21-Jan-2022

$1

$0.99 (9900.00%)

3 years 5 months 26 days ago
(20-Mar-2023)

0/2 (0%)

$0.79 (376.19%)

Hold Since 17-Mar-2023

$5

3 years 5 months 29 days ago
(17-Mar-2023)

0/2 (0%)

$3 (150.00%)

Buy Since 30-Dec-2021

$5

$4.99 (49900.00%)

$11

3 years 9 months 30 days ago
(16-Nov-2022)

0/4 (0%)

$3.08 (160.42%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on PEAR (Pear Therapeutics)?

Which analyst has the most public recommendations on PEAR (Pear Therapeutics)?

has 0 price targets and 0 ratings on PEAR

Which analyst is the currently most bullish on PEAR (Pear Therapeutics)?

Neena Bitritto-Garg with the highest potential upside of $4.99

Which analyst is the currently most reserved on PEAR (Pear Therapeutics)?

Marie Thibault with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?